Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation.
Rickey A EvansKrysta S WalterLeonard Jason LoboRaymond CoakleyChristina T DoligalskiPublished in: Clinical transplantation (2022)
CLAD should be identified as early as possible along with prompt intervention to optimize the possibility of stabilizing or improving lung function. More robust clinical data is needed to validate the use of all currently available and investigational treatment options for CLAD to identify the optimal pharmacotherapy management for this patient population.
Keyphrases
- lung function
- cystic fibrosis
- air pollution
- chronic obstructive pulmonary disease
- smoking cessation
- randomized controlled trial
- case report
- electronic health record
- extracorporeal membrane oxygenation
- oxidative stress
- big data
- clinical trial
- kidney transplantation
- phase ii
- artificial intelligence
- open label
- drug induced